Trials / Unknown
UnknownNCT05229575
Breast Stereotactic Radiotherapy to Primary Tumors in Metastatic Patients
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 30 (estimated)
- Sponsor
- Campus Bio-Medico University · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a dose escalation study involving stage IV breast cancer patients not progressing after 6 months of first line systemic treatment. Potential advantages of stereotactic body radiotherapy (SBRT) in treating breast primary tumor in metastatic breast cancer are: * radio-biological advantage of a short highly effective treatment schedule * possibility of preventing lesions to become symptomatic * possibility of continuing systemic treatment without interruption
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic Body Radiation Therapy (SBRT) | Undergo SBRT |
Timeline
- Start date
- 2020-07-10
- Primary completion
- 2022-10-10
- Completion
- 2023-04-10
- First posted
- 2022-02-08
- Last updated
- 2022-02-08
Locations
1 site across 1 country: Italy
Source: ClinicalTrials.gov record NCT05229575. Inclusion in this directory is not an endorsement.